OncoSwift® Melanoma Comprehensive
Unique Identifier:
ML-L011
Name on Requisition:
OncoSwift® Melanoma Comprehensive
Product Line:
LB
Panel Group:
Liquid Biopsy Panels
Panel Name:
OncoSwift® Melanoma Multi-Omics
Methodology
Molecular
NGS
Test Description and clinical significance
Genes
APC, ARID2, ATM, BRAF, BAP1, BRCA2, CCND1, CDK4, CDKN2A, CHEK2, CTNNB1, EIF1AX, FBXW7, GNA11, GNAQ, GNAS, IDH1, KIT, MAP2K1, MAP2K2, NF1, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PDGFRA, PIK3CA, PTEN, RB1, RET, ROS1, SF3B1, SMO, SRC, TERT, TP53
Disease:
cutaneous and non-cutaneous melanoma
The OncoSwift® Melanoma Comprehensive Panel identifies mutations, fusions, and copy number alterations across genes implicated in cutaneous and non-cutaneous melanoma. It delivers diagnostic and therapeutic information, including detection of actionable BRAF, NRAS, and KIT variants.
Specimen Requirements
Preparation:
PB
Collection:
Two tubes of peripheral blood (10mL/tube) are collected in PAXgene Blood ccfDNA tube
Stability:
7 to 10 days at room temperature
Unacceptable Conditions:
Specimen submitted is not in the PAXgene Blood ccfDNA Tubes or n the PAXgene Blood ccfDNA tube after expired date. Insufficient specimen (less than 10 mL whole blood/tube). Specimen is leaking from the collection tube, or the glass tube is broken. Gross hemolysis. Bacterial overgrowth
Submitted with incomplete requisition form (unless a requisition is subsequently sent). Unlabeled or improperly labeled specimens, without contact information or when failing to reach the ordering physician for clarification. cfDNA shipped in inappropriate temperature .
Storage & Transport
7 to 10 days at room temperature
CPT(s)
81464
New York Approved
Yes
TAT
7
Requisition Type
LB
Levels of Service
Full
DexS Code
Z05CG
Prefix
MI
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
